TrialCancer medicine2020

Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.

Pasquale F Innominato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.